Home » Metro » Health and Science
Cancer drug may add years
Print Edition
A DRUG developed in Shanghai that could allow people with terminal stomach cancer to live for years longer has been approved by the China Food and Drug Administration.
The Apatinib Mesylate tablet, made by the Jiangsu Hengrui Medicine Co, is the only oral drug for late stomach cancer in the world.
The drug blocks the growth of new blood cells in cancer tissue.
Clinical trials involving 38 hospitals across the country confirmed the drug’s efficacy, with the longest survival period recorded being some 44 months, experts said.
There were more than 952,000 cases of stomach cancer recorded worldwide last year — with 47 percent of those in China.
Experts say the incidence is much higher than Western countries due to the high infection rate of Helicobacter pylori bacteria, which is linked to stomach cancer. Traditional eating habits, such as sharing dishes, make it easier for the bacteria to spread.
Preserved foods popular in China have also been linked to the cancer.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
